Delcath Systems, Inc. (DCTH)
NASDAQ: DCTH · Real-Time Price · USD
10.89
-0.23 (-2.07%)
At close: Aug 25, 2025, 4:00 PM
10.89
0.00 (0.00%)
After-hours: Aug 25, 2025, 4:00 PM EDT
Delcath Systems Market Cap
Delcath Systems has a market cap or net worth of $380.42 million as of August 25, 2025. Its market cap has increased by 74.43% in one year.
Market Cap
380.42M
Enterprise Value
301.28M
1-Year Change
74.43%
Ranking
Category
Stock Price
$10.89
Market Cap Chart
Since May 10, 2018, Delcath Systems's market cap has increased from $2.70M to $380.42M, an increase of 13,989.67%. That is a compound annual growth rate of 97.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 389.00M | 1.04% |
| Dec 31, 2024 | 385.00M | 319.85% |
| Dec 29, 2023 | 91.70M | 195.81% |
| Dec 30, 2022 | 31.00M | -45.61% |
| Dec 31, 2021 | 57.00M | -22.76% |
| Dec 31, 2020 | 73.80M | 9,125.00% |
| Dec 31, 2019 | 800.00K | -68.00% |
| Dec 31, 2018 | 2.50M | -7.41% |
| May 10, 2018 | 2.70M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 638.90B |
| Johnson & Johnson | 431.79B |
| AbbVie | 372.04B |
| UnitedHealth Group | 278.42B |
| Novo Nordisk | 253.97B |
| AstraZeneca | 251.25B |
| Novartis AG | 246.51B |
| Abbott Laboratories | 230.77B |